 2 

   	 
       
      ! " #   
$ % &
' ( )  pentobarbital * +  
 ! , - # ./   
0     
1
2  3 4 5 6 7 8 9 :;< = >  ? @ A= > B (SAP)
CD A= > B (MSAP)E
 F G(HR)H = > B ICD = > B J KL M N O = &
 P Q (NA) R S T U V W@
 5 
X @ Y Z L-Glu
     [ NMDA\ non-NMDA:]A1    

^ [X @ Y Z ionotropic glutamate:]A_ ` W kynurenate ab cd e X @ Y Z
kynurenate; NAf
g0  = > B h O i j k 
Y Z gl W@ m kynurenate (0.1, 
0.2, 0.4E 0.8nmol)n
0o p [ 1nmol q r s1     j l  5 Y Z gl
W@ NMDA :]A_ ` W AP-5 (1, 2, 4E 8nmolet
uvo p [ 1nmol q r s1  
  :N Y Z gl W@ w x w yNMDA :]A_ ` W CNQX (0.1, 0.2, 0.4E 0.8nmolet

uvo p [ 1nmol q r s1     z { uvM | 
}~ Â€  ! Â R 
ionotropic glutamate:]AÂ‚i   
Âƒ Â„ NAo Â…  F GR Â† Â‡ Âˆ Â‰ ÂŠ Â‹ ÂŒ Â 
l fÂ b Â 
NA R :]AÂ Â‘ NMDA:]A
Â’  non-NMDA:]A


Â“ Â” Â• Â–P Q Â—Â˜ Â™ Âš q r s:]AÂ—       	
        :]AÂ—          	
     
   :]AÂ—   






















 4 
k Â‘   Â = #  
 Â…  h  B  
  ÂŠ AÂ´ Â¿ Ã€GÂ’ Ã•  
    Â­   

 ] Â’  Â© ! " = # # $ %  
Â‘Ã˜ "& ' &
1 ( $ Ã” ) Â« 5 
* z { j H  + , 

Â - . /  0 1 [mÃª ( )  2 3 
z { 4 Ã® 5 6   Â 
K %    Ã° Ã‰Ã± 
  7 Âµ 7 [Hsieh et al., 1988]
) 8   k Â‘   7 Ã“ Â† 
 9 Ã‰Â› Âœ Â = # K
j l \ : Â“ 9 Âš  
a ; 
Â‰ Â€ 2 3 Â 
Ã‚  Â < k Â› Âœ = # c 
 b Â Â Â‘ ionotropic q r s:]AÃ‡ =
KNMDAI non-NMDA :]A 1998>fÂ’  ?  P Q (NA) R Â  Ã¾ @ K NMDA
I non-NMDAÂ® ":]A[Neff et al, 1998]agl Â‘Â› Âœ = #  
Â©:]A A Â Â‘ B
"CA Ã‰Â› Âœ = # K B D E \j Â“ 9 1
z { < k Â¾ Â‘  P Q R F[q r s  m
   :]AÂ Â‘ NMDA\ non-NMDA :]A G  Â‰ 0 1  

  " # 
' c 
 1   m= # Â­Ã· H  Â§Ocadia sinensis 
Â¨gÂ¬Âš I 
A 	 J Â­ 1.0 K L ~1.7
K L  M N 
 N Ãƒ  O Â‘-10~0Pm Q R S Â´ J T U Â¬ V 
  Â© W X  * + Ã v:N 

Ãƒ Â© Y $  Z K [ \ ]  O \ ^ Â´ 
 _ ` a R 
 b c   d &./ 6 7  e 8 
Â¬ I Âª f 6
4 g h m< i > 7 h < = > 7 I Y Ã† j 7 Â¥ 7  k l m n Â§Sodium pentobarbital, 
15~25mg/kgÂ¨./ i > Y Z * + Â§c 
 Â c o p q 1.25mg/hr Â¨* + n
 r s t Z = #
AR 
 Â©A d u c  J 2vPw g x ; Y Ã† j 7 Â¥ 7 R 9 : y z { | ÃŠ (respirator, Harvard 
model-665t
l f   Â· } i ~  Â€ ÃŠ Ã¯Spegas, model 321-ETS-100t
 7 { j Â Â· } i ~ Â‚
 Ã¯expiratory end-tidal CO2 concentrationt
  = # m { j Â Â· } i ~ Â‚  u c  3.5~5Âƒ
   7 Ã“ Â†  Â„ 
[ g h < = > 7 9 :  B Ã¼ Â… Â† ÃŠ Â§Pressure transducer, Gould P231D 
Â¨
Ã„ 9 :   Â‡ Âˆ Ã³ ÃŠ Â§Electrostatic recorder, Gould ES 1000 
Â¨Â¬ I }~B Ã¼ Â‰ Ã Ã­ Â¯ ÃŠ
Â§Pressure Processor, Gould 13-4615-52 Ã³Â¨ ÂŠ = >  B (Systemic Artery Pressure, SAP)
x ^ [
Ã˜ Â¹ Âº , Â‹  Â±  Ã­ Â¯ ÃŠ Â§Universal, Gould 13-4615-58 ÂŒÂ¨ Â $ Ã³ ÂŠ CD  B Â§Mean Systolic 
Artery Pressure, MSAP)
I, Â‹  Ã’ # ÂŒ Â ÃŠ (Biotack, Gould 13-4615-66)
ÂŒ Â $  Â G
Â§Heart Rate, HR 
Â¨ Â Ã‡ Ãˆ Â‘ ÂŠ Ã° Â  
Ãƒ  Â‘ Â’ A Â“ Â¾ Â” R Â• Â“ Â– Ã· n
Ãƒ  m Â— Â˜ Â§OccipitalÂ¨I Â™ Â¬ Âš Â˜ Â§ParietalÂ¨
 Â˜ Â› Âœ  Â› Ã¡ 
 Âš Â˜ Â® Â Â› Ã›
 Â ;Â‰ ÂŸ  Â½ Â  Â¡ Â‘ Ã¶ Â¢ R  
 x KÂ‰ Â£  7
Â¤ Â¥ a/ 
Â¬ I  Â¦ Â§ u Â¨ Ãª nÂ· Ã« 
Ã„  Âœ e 8 Â› Ã›
Âª nÃ« 1 Â¨  Â§ 
Â‰  Â„ Â¥ n Â© 

Âª Â‰  Â„  Âœ Ã†  Â« Â¬ Â§Aaron, Cautery AA90Â¨Ãƒ  Â½ Ã‰ Â­ Â˜ 9 : Â‰ m  7 Â« Â® Â¯ u
o
p Â°  
 Â±    Â™ Â¬Â–Â² Â³ Â´  Âµ T  Â¶ Â§Â· ventricleÂ¨ Â¸ Â¹ Â§ObexÂ¨m Âº Â„ Â­ Â» Â¼
Â§Stereotaxic zero 
Â¨ Â½  Â’ A Â“ Â¾ Â” Â¾ $ j k m Â¿ Ã€ 
./ i Ã‚   c 
  
Kynurenic acid(Kyn) Â‰ " L Ã Ã‚ Ã§    Âš Ãƒ Ã„ s(excitatory amino acid, EAA) 
_ ` W(antagonistt[Zhang and Mifflin, 1995 ]Â­Ã± b Â   R NA:]A 9 Â
Â‘ ionotropic q r s:]A
gl W@ m kynurenic aciÃ…
Â¬ I Â­ 0.1, 0.2, 0.4 I 0.8 nmol

X @ Y Z    NA   R a ; Â¬ I Y Z KynmÃª IY Z Â– 30Â¬ V E 60Â¬ V n
 6 
Ã„ G Â­Ã± b Â   R NA :]A 9 Â Â‘ NMDA :]A1z { 2   
NMDA :]A_ ` W AP-5./ Y Z Ã¨ 2AÂ­W@ Â­ 8 nmolm AP-5
./ X @ Y Z
   NA   R Fa ; Â¬ I Y Z AP-5mÃª IY Z 20h60Â¬ V nÃ„ X @ Y Z q r
sFÂ‘l Â‰ Â¾ O 1 Ã³ Ã’   B   Ã¨Â©Â 1Â¬ I Â¿ Âº = > B hCD = > B I
F GÃ³ ÂŠ z { Ã´  Ã³ ÂŠ Âƒ Â„ 
AP-5 k   F GO i @ m % Ãµ  
Â© uv Ãµ Ã¨ 2B Âº 1| Ã¶Â©Â Â¤ Â¿ Ã€ Â¿ Âº q r s1    O i @ 
 Ã Â¿ Ã€
Â¬ I Â¿ Âº AP-5gl W@ / (1, 2, 4,E 8nmol)[Ã¨ 2AI 2BM | z {   ;
 AP-5
W@ 4nmol Y Z n 20Â¬ V Ã„ Y Z q r sf
 Ã¸ 0KÃ™ Ã¹      
aY Z n 60Â¬
V Ã„ Y Z q r s
Â©   Ã¸ Ãº Ã» Ã± Ã£ Ã˜ z { b Â   R NA :]AÂ Â‘
NMDA :]Aj l 
Â©Ã™ Ã¹ Ã v Ã· W@ U V aU Â¯ 
a ; U V W@ ; 8nmolf

Â©Ã™  Ã v A  + 
Ã„ G Â­Ã± b Â   R NA:]A 9 Â Â‘ non-NMDA :]A
12  
non-NMDA :]A_ ` W CNQX
./ Y Z Ã¨ 3AÂ­W@ Â­ 0.8 nmolm CNQX
.
/ X @ Y Z    NA   R Fa ; Â¬ I Y Z  CNQXmÃª IY Z 20h60Â¬ V n
Ã„ X @ Y Z q r sFÂ‘l Â‰ Â¾ O 1 Ã³ Ã’   B   Ã¨Â—Â©Â 1Â¬ I Â¿ Âº = > B hC
D = > B I F GÃ³ ÂŠ Â© uv Ãµ Ã¨ 3BÃ¶Â©Â Â¤ Â¿ Ã€ Â¿ Âº q r s1  
 O i @ 
 Ã Â¿ Ã€ Â¬ I Â¿ Âº CNQXgl W@ / (0.1, 0.2, 0.4E 0.8nmol)[Ã¨ 3AI
3B Âº M | z {   ;
 CNQXW@ 0.4nmol Y Z n 20Â¬ V Ã„ Y Z q r sf
 Ã¸ 0K
Ã™ Ã¹      aY Z n 60Â¬ V Ã„ Y Z q r s
Â©   Ã¸ S  Ãº Ã» Ã± 1
z { Â’ b Â   R NA:]AÂ Â‘ non-NMDA :]A Ã˜ m
Â©Ã™ Ã¹ 
Ã v Ã· W@ U V aU Â¯ 
W@ U V ; 0.8nmol f  
Â©Ã™ Ã¹ Ã v  + 
[z { c 
 uvb Â F  R DMV/NA
[q r s     :
]AÂ Â‘ ionotropic q r s:]A; Â©  Â¼ Â¾ O [ Ã™ Ãš Ã¨ 4 R  | M |  Âƒ l fF
z { Â b Â 
  R DMV/NA
[q r s     :]A Ã± = K NMDA 
:]A
Â Ã‡ = K non-NMDA :]AÃ˜ uvÃ‰ 1998> NeffÃ¨Ã‚   $ Â› Âœ = #  NA
R Ã‡ = K NMDAI non-NMDA :]Aj 	 Ã [Neff et al, 1998]

) * + , 
Bliss, T.V.P. and Collingridge, G.L. A synaptic model of memory: long-term potentiation in the 
hippocampus. Nature. 361: 31-39, 1993. 
Collingridge, G.L., Watkins, J.C. The NMDA ReceptorCollingride, G.L., Watkins, J.C., eds
2nd ed., pp 1-103, 1994. 
Cotman, C.W. and Iversen, L.L. Excitatory amino acid in the brain: focus on NMDA receptors. 
Trends Neurosci. 10: 263-265, 1987. 
Donevan, S.D. and Rogawski, M.A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, 
neuroprotective antagonist of AMPA/kainite receptor reponses. Neuron.  10:51-59, 1993. 
 8 

                           
     Ã¨ 1AhW@ Â­ 0.4 nmolm kynurenic acid
./ X @ Y Z    NA   R 

a ; Â¬ I Y Z KynmÃª IY Z 30h60Â¬ V nÃ„ X @ Y Z q r s
Â‘l Â‰ Â¾ O 1 Ã³ Ã’
  B   Ã¨
 
 
   
Ã¨ 1Bhionotropic q r s:]A_ ` W Kyn./ NAÂ¾ O Y Z 
1  uvÂ¡ ÂŒ
Ã¨Âº Â©Â Â¤ Â¿ Ã€ Â¿ Âº q r s1    O i @ 
Ã Â¿ Ã€ Â¬ I Â¿ Âº Kyngl W
@ / (0.1, 0.2, 0.4E 0.8 nmole)[Ã¨Âº M | z {   ;
 KynW@ 0.2nmolY Z n
30Â¬ V Ã„ Y Z q r sf
Ã¸ 0KÃ™ Ã¹      
aY Z n 60Â¬ V Ã„ Y Z q r s

Â©   Ã¸ Ãº Ã» Ã± 
 
 
L-Glu L-Glu L-Glu 
40 
10 
SAP 
(mmHg) 
10 
40 
MSAP 
(mmHg) 
0 
50 
HR 
(bpm) 
30 min After 60 min After Before KYN 
1 min 
 10 
 
                         
   Ã¨ 3AhW@ Â­ 
  8 nmolm CNQX
./ X @ Y Z    NA   R 
a ; Â¬ I
Y Z  CNQXmÃª IY Z 20h60Â¬ V nÃ„ X @ Y Z q r s
Â‘l Â‰ Â¾ O 1 Ã³ Ã’   B
  Ã¨
 
 
Ã¨ 3Bhw x w yNMDA :]A_ ` W CNQX./ NAÂ¾ O Y Z 
1  uvÂ¡ ÂŒ Ã¨Âº 
Â©Â Â¤ Â¿ Ã€ Â¿ Âº q r s1    O i @ 
 Ã Â¿ Ã€ Â¬ I Â¿ Âº  CNQXgl W@ /
(0.1, 0.2, 0.4E 
  8 nmole)[Ã¨Âº M | z {   ;
 CNQXW@ 0.8nmolY Z n 20
Â¬ V Ã„ Y Z q r sf
Ã¸ 0KÃ™ Ã¹      
aY Z n 60Â¬ V Ã„ Y Z q r s
Â©
  Ã¸ Ãº Ã» Ã± 

40 
10 
SAP 
(mmHg) 
10 
40 
MSAP 
(mmHg) 
0 
50 
HR 
(bpm) 
20 min After 60 min After Before CNQX 
L-Glu L-Glu L-Glu 
1 min 
